These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342 [TBL] [Abstract][Full Text] [Related]
4. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. Selin LK; Varga SM; Wong IC; Welsh RM J Exp Med; 1998 Nov; 188(9):1705-15. PubMed ID: 9802982 [TBL] [Abstract][Full Text] [Related]
5. PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection. Kraft AR; Wlodarczyk MF; Kenney LL; Selin LK J Virol; 2013 Dec; 87(23):12636-47. PubMed ID: 24049180 [TBL] [Abstract][Full Text] [Related]
6. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections. Mueller SN; Langley WA; Li G; García-Sastre A; Webby RJ; Ahmed R J Immunol; 2010 Aug; 185(4):2182-90. PubMed ID: 20639484 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. Schmitz N; Kurrer M; Bachmann MF; Kopf M J Virol; 2005 May; 79(10):6441-8. PubMed ID: 15858027 [TBL] [Abstract][Full Text] [Related]
8. Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Chen J; Duan M; Zhao Y; Ling F; Xiao K; Li Q; Li B; Lu C; Qi W; Zeng Z; Liao M; Liu Y; Chen W Oncotarget; 2015 Dec; 6(40):42541-56. PubMed ID: 26637810 [TBL] [Abstract][Full Text] [Related]
9. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. Sun K; Torres L; Metzger DW J Virol; 2010 May; 84(10):5007-14. PubMed ID: 20200252 [TBL] [Abstract][Full Text] [Related]
10. Virus infection-associated bone marrow B cell depletion and impairment of humoral immunity to heterologous infection mediated by TNF-alpha/LTalpha. Borrow P; Hou S; Gloster S; Ashton M; Hyland L Eur J Immunol; 2005 Feb; 35(2):524-32. PubMed ID: 15657949 [TBL] [Abstract][Full Text] [Related]
11. Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity. Lauder SN; Taylor PR; Clark SR; Evans RL; Hindley JP; Smart K; Leach H; Kidd EJ; Broadley KJ; Jones SA; Wise MP; Godkin AJ; O'Donnell V; Gallimore AM Thorax; 2011 May; 66(5):368-74. PubMed ID: 21310755 [TBL] [Abstract][Full Text] [Related]
13. IL-12 is not required for induction of type 1 cytokine responses in viral infections. Oxenius A; Karrer U; Zinkernagel RM; Hengartner H J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721 [TBL] [Abstract][Full Text] [Related]
14. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion. Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703 [TBL] [Abstract][Full Text] [Related]
15. Helper T Cell Responses to Respiratory Viruses in the Lung: Development, Virus Suppression, and Pathogenesis. Miyauchi K Viral Immunol; 2017; 30(6):421-430. PubMed ID: 28650258 [TBL] [Abstract][Full Text] [Related]
16. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses. Damjanovic D; Lai R; Jeyanathan M; Hogaboam CM; Xing Z Am J Pathol; 2013 Sep; 183(3):868-80. PubMed ID: 23831294 [TBL] [Abstract][Full Text] [Related]
17. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Bründler MA; Aichele P; Bachmann M; Kitamura D; Rajewsky K; Zinkernagel RM Eur J Immunol; 1996 Sep; 26(9):2257-62. PubMed ID: 8814275 [TBL] [Abstract][Full Text] [Related]
18. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. Bukowski JF; Welsh RM J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125 [TBL] [Abstract][Full Text] [Related]
19. Cytokine-Mediated Activation of NK Cells during Viral Infection. Freeman BE; Raué HP; Hill AB; Slifka MK J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253 [TBL] [Abstract][Full Text] [Related]
20. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Newton AH; Cardani A; Braciale TJ Semin Immunopathol; 2016 Jul; 38(4):471-82. PubMed ID: 26965109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]